In human HCC cell lines, integrins α1β1 and α2β1 inhibition reduces migration induced by profibrotic growth factors including TGF-β1, epidermal growth factor (EGF) and fibroblast growth factor (FGF) [32]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.